Alpha Signal Monitor - Daily Market Briefing | February 06, 2026
Daily Market Research Report
February 06, 2026
Alpha Signal Monitor
Welcome to your daily pre-market briefing. This report provides key insights on market opportunities and analyst perspectives to help identify potential alpha signals.
Today's Coverage: - Gold ETF Outlook: Institutional perspectives on gold-backed ETFs - Stock Ratings: Latest analyst ratings and target prices for our watchlist - IPO Calendar: Upcoming initial public offerings and market debuts
Watchlist Stocks: AAPL, MSFT, GOOGL, AMZN, NVDA, META, TSLA, AVGO, TSM
This report is generated using advanced AI research capabilities with real-time market data access.
Gold ETF outlook (GLD, IAU, BAR) — as of February 6, 2026
Trading Idea: Buy Rationale (TL;DR): Institutional consensus has turned more bullish into 2026 on structural demand from central banks and increasingly sticky private‑sector diversification into bullion, alongside an easing Fed and softer real yields; several houses raised 2026 targets in late January, reinforcing a pro‑gold stance for broad, physically backed ETFs like GLD/IAU/BAR. (straitstimes.com)
After a record 2025, gold made fresh highs in January 2026 before a sharp, policy‑driven pullback; banks characterized the dip as tactical and subsequently lifted or reaffirmed higher 2026 targets. Structural flows (official sector and ETFs/private allocations) and expectations for lower real rates remain supportive; recent forecast upgrades from Goldman Sachs and UBS and a higher target from JPMorgan anchor the bull case. (finance.yahoo.com)
Key Drivers - Official‑sector buying expected to remain elevated (~800–950t in 2026) supporting prices and ETF demand. - Private‑sector diversification into gold increasingly viewed as ‘stickier’ allocation, not just a tactical hedge. - Fed easing path and softer/lower real yields reduce the opportunity cost of holding gold. - Dollar weakness and ongoing geopolitical/policy uncertainty (trade tensions, fiscal concerns) sustain safe‑haven demand. - ETF inflows resuming/accelerating after multi‑year net‑selling, reinforcing physically backed ETF holdings. - Limited mine supply responsiveness at higher prices tightens balances during demand upswings.
| Institution | Stance | Price View | Key Evidence | Last Update | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Bullish | Gold $5,400/oz by Dec 2026 (raised from $4,900). | Upgrade cites private‑sector diversification on top of strong central‑bank/ETF demand; positions seen as sticky through 2026. | 2026-01-21 | (uk.finance.yahoo.com) |
| Morgan Stanley | Positive | Gold $4,800/oz by Q4 2026. | Drivers include falling rates, Fed leadership change, central‑bank and fund buying, and safe‑haven demand. | 2026-01-06 | (investing.com) |
| JP Morgan | Bullish | Gold $6,300/oz by end‑2026. | Sees stronger‑than‑expected official‑sector and investor demand; projects ~800t central‑bank buying in 2026. | 2026-02-02 | (marketwatch.com) |
| Bank of America | Positive | Targets $5,000/oz in 2026; 2026 average around $4,400. | BofA Global Research sees the rally as not extreme; a ~14% investment‑demand increase could lift gold to $5,000. | 2025-10-28 | (investing.com) |
| Citigroup | Neutral/Cautious | 2026 average ~$3,250/oz (base case); near‑term targets adjusted tactically in 2025. | Citi maintained a more conservative 2026 base forecast while acknowledging upside scenarios; earlier raised short‑term targets amid strong flows. | 2025-10-28 | (tradingview.com) |
| UBS | Attractive/Overweight | $6,200/oz for Mar/Jun/Sep 2026; ~$5,900 by end‑2026 (bull case $7,200). | Upgrade reflects heavy investment inflows, robust central‑bank demand (~950t) and elevated policy/geopolitical uncertainty; CIO remains long gold in allocation. | 2026-01-29 | (investing.com) |
| HSBC | Constructive | Upside to $5,000/oz in 1H 2026; 2026 average ~$4,600. | Expects rally supported by geopolitical risks, policy uncertainty and rising public debt; persistent ETF/official‑sector demand. | 2025-10-17 | (business-standard.com) |
| Deutsche Bank | Bullish | Sees $6,000/oz in 2026 (alt. scenario up to ~$6,900); prior base raised to $4,450. | Cites persistent investment demand and diversification into non‑USD/real assets; earlier base case lifted on stable flows and central‑bank buying. | 2026-01-27 | (marketscreener.com) |
Risk Considerations - Reacceleration of inflation that forces a hawkish Fed response and higher real yields. - Sustained USD strength, improving growth, or easing geopolitical tensions that dent safe‑haven demand. - A sharp slowdown in official‑sector purchases (e.g., EM central banks pause buying). - Positioning/unwind risk after a parabolic run, leading to outsized drawdowns and ETF outflows. - Liquidity/market‑structure stresses (e.g., futures basis dislocations) that pressure ETFs’ secondary‑market pricing. - Policy/regulatory changes altering reserve‑management behavior or ETF market access.
Bias remains higher into 2026 with multiple banks at $5,000–$6,300 price marks; for broad exposure we favor unlevered, physically backed ETFs (GLD/IAU/BAR). Consider staggered entries given elevated volatility and sensitivity to real rates; UBS’s CIO continues to advocate a mid‑single‑digit portfolio allocation to gold as strategic ballast. (investing.com)
Stock Ratings — Mega-cap Tech — Street Targets and Ratings (as of February 6, 2026)
Compiled latest published target prices and ratings from GS (高盛), MS (大摩), JPM (小摩), BAC/Bank of America (美银), Citi/CG (花旗), and Wells Fargo (富国银行). Dates are the most recent publication we could locate. Where a bank had no clear, dated figure, fields are set to null.
AAPL - Apple Inc.
Coverage skewed positive to Buy/Overweight across banks; most recent moves into late Jan 2026.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $330 | 2026-01-30 | - | https://www.pricetargets.com/NASDAQ/AAPL/ |
| Morgan Stanley | Overweight | $315 | 2025-12-17 | - | https://www.pricetargets.com/NASDAQ/AAPL/ |
| JP Morgan | Overweight | $325 | 2026-01-30 | - | https://www.pricetargets.com/NASDAQ/AAPL/ |
| Bank of America | Buy | $250 | 2025-08-07 | - | https://www.pricetargets.com/NASDAQ/AAPL/ |
| Citigroup | Buy | $315 | 2026-01-20 | - | https://www.pricetargets.com/NASDAQ/AAPL/ |
| Wells Fargo | Overweight | $300 | 2025-10-31 | - | https://www.pricetargets.com/NASDAQ/AAPL/ |
Consensus View - Rating: Moderate Buy, Target Price: $291.70 - MarketBeat analyst consensus (36 analysts) as of 2026-02-05.
MSFT - Microsoft Corp.
Broad reset of targets around Jan 29, 2026 post-earnings; stance remains Buy/Overweight at all six banks.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $600 | 2026-01-29 | - | https://www.pricetargets.com/NASDAQ/MSFT/ |
| Morgan Stanley | Overweight | $625 | 2025-09-26 | Most recent MS figure with explicit target; 2026-01-29 entry reiterated rating without a target. | https://www.pricetargets.com/NASDAQ/MSFT/ |
| JP Morgan | Overweight | $550 | 2026-01-29 | - | https://www.pricetargets.com/NASDAQ/MSFT/ |
| Bank of America | Buy | $520 | 2026-01-26 | - | https://www.pricetargets.com/NASDAQ/MSFT/ |
| Citigroup | Buy | $635 | 2026-01-29 | - | https://www.pricetargets.com/NASDAQ/MSFT/ |
| Wells Fargo | Overweight | $615 | 2026-01-29 | - | https://www.pricetargets.com/NASDAQ/MSFT/ |
Consensus View - Rating: Moderate Buy, Target Price: $593.28 - MarketBeat analyst consensus (45 analysts) as of 2026-02-05.
GOOGL - Alphabet Inc.
Post-earnings on Feb 5, 2026 saw widespread target hikes; GS and JPM set among the highest from these banks.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $400 | 2026-02-05 | - | https://www.investing.com/news/analyst-ratings/goldman-sachs-raises-alphabet-stock-price-target-to-400-on-strong-cloud-growth-93CH-4486851 |
| Morgan Stanley | Overweight | $330 | 2025-10-30 | Latest dated MS target we found; 2026 entries reiterated rating without a new target. | https://www.gurufocus.com/news/3172847/googl-morgan-stanley-raises-price-target-amid-overweight-rating-googl-stock-news |
| JP Morgan | Overweight | $395 | 2026-02-05 | - | https://www.pricetargets.com/NASDAQ/GOOGL/ |
| Bank of America | Buy | $370 | 2026-01-13 | - | https://www.gurufocus.com/news/4108093/googl-b-of-a-securities-raises-price-target-to-370-googl-stock-news |
| Citigroup | Buy | $350 | 2026-01-08 | Raised as part of 2026 outlook; maintains Buy/Outperform. | https://www.tipranks.com/news/the-fly/alphabet-price-target-raised-to-350-from-343-at-citi-thefly |
| Wells Fargo | Equal Weight | $354 | 2026-02-05 | - | https://www.pricetargets.com/NASDAQ/GOOGL/ |
Consensus View - Rating: Moderate Buy, Target Price: $354.86 - MarketBeat analyst consensus (52 analysts) as of 2026-02-05.
AMZN - Amazon.com Inc.
Targets mostly refreshed through Jan–Feb 2026; banks remain constructive despite higher capex path.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $300 | 2026-01-14 | - | https://www.pricetargets.com/NASDAQ/AMZN/ |
| Morgan Stanley | Overweight | $300 | 2025-07-10 | - | https://www.pricetargets.com/NASDAQ/AMZN/ |
| JP Morgan | Overweight | $305 | 2025-12-12 | - | https://www.pricetargets.com/NASDAQ/AMZN/ |
| Bank of America | Buy | $286 | 2026-01-27 | - | https://www.pricetargets.com/NASDAQ/AMZN/ |
| Citigroup | Buy | $320 | 2025-10-31 | - | https://www.pricetargets.com/NASDAQ/AMZN/ |
| Wells Fargo | Overweight | $301 | 2026-01-12 | - | https://www.pricetargets.com/NASDAQ/AMZN/ |
Consensus View - Rating: Moderate Buy, Target Price: $296.37 - MarketBeat analyst consensus (59 analysts) as of 2026-02-05.
NVDA - NVIDIA Corp.
All six cover; latest numeric targets cluster $200–$275 after 2H25 resets; WFC recent figure not found.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $185 | 2025-07-10 | Initiated coverage. | https://www.pricetargets.com/NASDAQ/NVDA/ |
| Morgan Stanley | Overweight | $250 | 2025-12-01 | - | https://www.pricetargets.com/NASDAQ/NVDA/ |
| JP Morgan | Overweight | $215 | 2025-09-04 | - | https://www.pricetargets.com/NASDAQ/NVDA/ |
| Bank of America | Buy | $275 | 2025-12-26 | - | https://www.pricetargets.com/NASDAQ/NVDA/ |
| Citigroup | Buy | $200 | 2025-09-08 | Lowered from $210. | https://www.pricetargets.com/NASDAQ/NVDA/ |
| Wells Fargo | - | - | - | No recent, clearly dated WFC NVDA target found on the sources queried. | https://www.pricetargets.com/NASDAQ/NVDA/ |
Consensus View - Rating: Buy, Target Price: $263.98 - MarketBeat analyst consensus (53 analysts) as of 2026-02-05.
META - Meta Platforms Inc.
All banks except GS showed fresh 1/29/2026 updates with high-800s targets; GS recent figure not located in time window.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | Could not locate a clearly dated GS META target in 2025–2026 within source limits. | - |
| Morgan Stanley | Overweight | $825 | 2026-01-29 | - | https://www.pricetargets.com/NASDAQ/META/ |
| JP Morgan | Overweight | $825 | 2026-01-29 | - | https://www.pricetargets.com/NASDAQ/META/ |
| Bank of America | Buy | $885 | 2026-01-29 | - | https://www.pricetargets.com/NASDAQ/META/ |
| Citigroup | Outperform | - | 2026-01-29 | Reiterated rating; no numeric target displayed in public table. | https://www.pricetargets.com/NASDAQ/META/ |
| Wells Fargo | Overweight | $849 | 2026-01-29 | - | https://www.pricetargets.com/NASDAQ/META/ |
Consensus View - Rating: Moderate Buy, Target Price: $848.50 - MarketBeat analyst consensus (53 analysts) as of 2026-02-05.
TSLA - Tesla Inc.
Mixed views; MS Overweight, BAC Neutral; JPM and WFC remain Underweight with lower targets in early 2025; GS cautious stance without public target.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Cautious | - | 2025-03-03 | Reiterated stance; no public target shown in table. | https://www.pricetargets.com/NASDAQ/TSLA/ |
| Morgan Stanley | Overweight | $430 | 2025-01-13 | - | https://www.pricetargets.com/NASDAQ/TSLA/ |
| JP Morgan | Underweight | $120 | - | Lowered from $135; date not clearly shown in the public snippet. | https://www.pricetargets.com/NASDAQ/TSLA/ |
| Bank of America | Neutral | $380 | 2025-03-04 | - | https://www.pricetargets.com/NASDAQ/TSLA/ |
| Citigroup | - | - | - | Could not locate a clearly dated Citi TSLA target in the 2025–2026 window via public tables. | https://www.pricetargets.com/NASDAQ/TSLA/ |
| Wells Fargo | Underweight | $135 | 2025-01-30 | - | https://www.pricetargets.com/NASDAQ/TSLA/ |
Consensus View - Target Price: $403.92 - MarketBeat price target (40 analysts) as of 2026-02-05; consensus rating not clearly displayed in public page.
AVGO - Broadcom Inc.
Positive stance across banks with several 4Q25 hikes tied to custom silicon/AI demand.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $435 | 2025-11-25 | - | https://www.pricetargets.com/NASDAQ/AVGO/ |
| Morgan Stanley | Overweight | $443 | 2025-12-01 | - | https://www.pricetargets.com/NASDAQ/AVGO/ |
| JP Morgan | - | - | - | No recent JPM AVGO entry located on public page. | https://www.pricetargets.com/NASDAQ/AVGO/ |
| Bank of America | Buy | $460 | 2025-12-01 | - | https://www.pricetargets.com/NASDAQ/AVGO/ |
| Citigroup | Buy | $415 | 2025-10-14 | - | https://www.pricetargets.com/NASDAQ/AVGO/ |
| Wells Fargo | - | - | - | No recent WFC AVGO entry located on public page. | https://www.pricetargets.com/NASDAQ/AVGO/ |
Consensus View - Rating: Buy, Target Price: $437.28 - MarketBeat analyst consensus (34 analysts) as of 2026-02-05.
TSM - Taiwan Semiconductor Manufacturing Co. (ADR)
Street targets are broadly positive, but among the six specified U.S. banks, recent, clearly dated public targets were limited.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | No recent public GS USD target located. | - |
| Morgan Stanley | - | - | - | No recent public MS USD target located. | - |
| JP Morgan | - | - | - | No recent public JPM USD target located. | - |
| Bank of America | - | - | - | No recent public BAC USD target located. | - |
| Citigroup | - | - | - | No recent public Citi USD target located. | - |
| Wells Fargo | - | - | - | No recent public WFC USD target located. | - |
Consensus View - Rating: Buy, Target Price: $381.67 - MarketBeat/Analyst Ratings Network consensus (13 analysts) as of 2026-02-04.
Highlights
- Alphabet: GS raised PT to $400 and JPM to $395 on Feb 5, 2026 following Q4 results and higher AI capex outlook.
- Microsoft: Broad wave of target resets on Jan 29, 2026; GS $600, JPM $550, Citi $635, WFC $615.
- Apple: GS Buy $330 and JPM Overweight $325 as of Jan 30, 2026; Citi Buy $315 (Jan 20, 2026).
- Meta: MS, JPM, BAC, and WFC targets clustered $825–$885 on Jan 29, 2026; Citi reiterated Outperform (target not shown).
- Amazon: GS $300 (Jan 14, 2026); BAC $286 (Jan 27, 2026); WFC $301 (Jan 12, 2026).
- NVIDIA: Latest bank targets mostly from 2H25; BAC $275, MS $250, JPM $215; WFC figure not found.
Notes: Figures reflect the most recent publicly available items we could source on February 6, 2026. Many bank research notes are paywalled; we used reputable aggregators (MarketBeat/Analyst Ratings Network via pricetargets.com, Investing.com, GuruFocus, and TipRanks/The Fly) and cited specific pages. Let me know if you’d like a bank-only consensus (average of just the six institutions) for each stock; I can compute that once any missing values are filled.
IPO Calendar
Timeframe: February 6, 2026 – March 6, 2026 (US equity markets)
The US IPO tape opens the period with one of the busiest weeks since 2021, led by a mix of consumer (Once Upon a Farm), biotech (Agomab Therapeutics, SpyGlass Pharma) and energy/infrastructure (SOLV Energy) deals, while one notable adtech (Liftoff Mobile) postponed on February 6 due to market conditions. Expect fewer firm dates beyond mid‑February because IPOs are typically scheduled only 7–10 days ahead. Overall tone: selective but improving, with larger pipelines for later in 2026. (axios.com)
Agomab Therapeutics NV (AGMB)
- Expected listing date: 2026-02-06
- Price range: $16.00 (final IPO price)
- Shares offered: 12,500,000 ADS (primary); 30‑day option for 1,875,000 ADS
- Exchange: Nasdaq Global Select Market
- Lead underwriters: J.P. Morgan, Morgan Stanley, Leerink Partners, Van Lanschot Kempen
- Business summary: Clinical‑stage biotech developing disease‑modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications; IPO proceeds fund pipeline advancement. (globenewswire.com)
- Notes: Trading expected to begin February 6, 2026 under “AGMB”; closing expected February 9, 2026, subject to customary conditions. Amounts are gross and exclude underwriting discounts/expenses. (globenewswire.com)
- Sources: Pricing press release, Feb. 5, 2026 (GlobeNewswire). (globenewswire.com), Follow‑up coverage (RTT News). (rttnews.com)
SpyGlass Pharma, Inc. (SGP)
- Expected listing date: 2026-02-06
- Price range: $16.00 (final IPO price)
- Shares offered: 9,375,000 shares (primary); 30‑day option for 1,406,250 shares
- Exchange: Nasdaq Global Select Market
- Lead underwriters: Jefferies, Leerink Partners, Citigroup, Stifel
- Business summary: Late‑stage ophthalmology company developing sustained drug‑delivery implants (e.g., BIM‑IOL System for glaucoma/ocular hypertension); offering to fund Phase 3 programs and platform expansion. (globenewswire.com)
- Notes: Trading expected to begin February 6, 2026 under “SGP”; closing expected February 9, 2026, subject to customary conditions. (globenewswire.com)
- Sources: Pricing press release, Feb. 5, 2026 (GlobeNewswire). (globenewswire.com)
Once Upon a Farm, PBC (OFRM)
- Expected listing date: 2026-02-06
- Price range: $18.00 (final IPO price)
- Shares offered: 10,997,209 shares (7,631,537 primary; 3,365,672 secondary); 30‑day option for 1,649,581 shares
- Exchange: NYSE
- Lead underwriters: Goldman Sachs & Co. LLC, J.P. Morgan, BofA Securities, William Blair, Barclays, Evercore ISI, Deutsche Bank Securities, Oppenheimer & Co., TD Cowen
- Business summary: Organic baby and kids food brand (Public Benefit Corporation) selling cold‑pressed pouches, meals and snacks via DTC and major retailers; proceeds to reduce debt, invest in operations, and for general corporate purposes. (markets.financialcontent.com)
- Notes: Trading expected to begin February 6, 2026 under “OFRM”; closing expected February 9, 2026, subject to customary conditions. (barchart.com)
- Sources: Pricing announcement (Business Wire), Feb. 5, 2026. (gurufocus.com), Additional distribution of the pricing release. (barchart.com)
Liftoff Mobile, Inc. (LFTO)
- Price range: $26.00 – $30.00 (filed range)
- Shares offered: 25,400,000 shares (base); 30‑day option for 3,810,000 shares
- Exchange: Nasdaq (applied)
- Lead underwriters: Goldman Sachs & Co. LLC, Jefferies, Morgan Stanley
- Business summary: Adtech platform providing AI‑powered user acquisition and ad monetization for mobile apps across >140,000 integrated apps and ~1.4B estimated daily active users; backed by Blackstone and General Atlantic. (prnewswire.com)
- Notes: Company postponed planned February 6, 2026 debut due to market conditions; timing now TBD (“market and other conditions”). Treat as on watch. (barrons.com)
- Sources: Roadshow launch announcement, Jan. 29, 2026 (PR Newswire). (prnewswire.com), Barron’s: IPO postponed on Feb. 6, 2026. (barrons.com)
AGI Inc (Agibank) (AGBK)
- Expected listing date: 2026-02-11 (expected)
- Price range: $15.00 – $18.00 (filed range)
- Shares offered: 43,636,364 Class A shares (base)
- Exchange: NYSE (proposed)
- Lead underwriters: Goldman Sachs, Morgan Stanley, Citigroup, Bradesco BBI, BTG Pactual, Itaú BBA, Santander, Société Générale, XP Investimentos
- Business summary: Brazil‑focused, tech‑enabled consumer bank serving underserved segments (e.g., social‑security beneficiaries, public/private sector workers) via a hybrid digital + 1,100+ “Smart Hubs” footprint. Listing via Cayman holding company. (renaissancecapital.com)
- Notes: Terms set Jan. 29, 2026; expected to price week of February 9. Note: Brazil’s INSS issued temporary suspensions to the company in 2025, per filings; monitor for regulatory updates. (renaissancecapital.com)
- Sources: Renaissance Capital: AGI (Agibank) sets terms ($15–$18; 43.6M shares; NYSE: AGBK). (renaissancecapital.com), Reuters syndications on target valuation/raise. (investing.com)
SOLV Energy, Inc. (MWH)
- Expected listing date: 2026-02-11 (expected)
- Price range: $22.00 – $25.00 (filed range)
- Shares offered: 20,500,000 shares (base); 30‑day option for 3,075,000 shares
- Exchange: Nasdaq (proposed)
- Lead underwriters: Jefferies, J.P. Morgan, KeyBanc Capital Markets, TD Cowen, UBS Investment Bank, Baird, Evercore ISI, Guggenheim Securities, Wolfe | Nomura Alliance, CIBC Capital Markets, Roth Capital Partners
- Business summary: EPC and O&M provider for utility‑scale solar and battery storage projects; one of the largest US solar contractors with >20 GWdc built and long‑term O&M on ~18 GWdc. Proceeds to repay debt and for general corporate purposes. (solvenergy.com)
- Notes: Launched roadshow Feb. 2, 2026; expected to price the week of Feb. 9. Final trade date subject to market conditions and exchange approval. (solvenergy.com)
- Sources: Company roadshow launch (Feb. 2, 2026). (solvenergy.com), Renaissance Capital terms summary. (renaissancecapital.com)
This calendar reflects information verified as of Friday, February 6, 2026. Dates and terms may change (or offerings may be postponed or withdrawn) at short notice; many US IPOs are set 7–10 days ahead of pricing. Treat entries marked “expected” as tentative. (stockanalysis.com)
Sources
- Stock Ratings: https://www.gurufocus.com/news/3172847/googl-morgan-stanley-raises-price-target-amid-overweight-rating-googl-stock-news, https://www.gurufocus.com/news/4108093/googl-b-of-a-securities-raises-price-target-to-370-googl-stock-news, https://www.investing.com/news/analyst-ratings/goldman-sachs-raises-alphabet-stock-price-target-to-400-on-strong-cloud-growth-93CH-4486851, https://www.pricetargets.com/NASDAQ/AAPL/, https://www.pricetargets.com/NASDAQ/AMZN/, https://www.pricetargets.com/NASDAQ/AVGO/, https://www.pricetargets.com/NASDAQ/GOOGL/, https://www.pricetargets.com/NASDAQ/META/, https://www.pricetargets.com/NASDAQ/MSFT/, https://www.pricetargets.com/NASDAQ/NVDA/, https://www.pricetargets.com/NASDAQ/TSLA/, https://www.tipranks.com/news/the-fly/alphabet-price-target-raised-to-350-from-343-at-citi-thefly
- IPO Calendar: https://markets.financialcontent.com/stocks/article/bizwire-2026-2-6-once-upon-a-farm-announces-pricing-of-initial-public-offering?utm_source=openai, https://stockanalysis.com/ipos/calendar/?utm_source=openai, https://www.axios.com/2026/02/04/ipo-forgent-spacex?utm_source=openai, https://www.barchart.com/story/news/60647/once-upon-a-farm-announces-pricing-of-initial-public-offering?utm_source=openai, https://www.barrons.com/articles/liftoff-mobile-postpone-ipo-market-c124331b?utm_source=openai, https://www.globenewswire.com/news-release/2026/02/06/3233533/0/en/SpyGlass-Pharma-Announces-Pricing-of-Initial-Public-Offering.html?utm_source=openai, https://www.globenewswire.com/news-release/2026/02/06/3233537/0/en/Agomab-Announces-Pricing-of-Initial-Public-Offering.html?utm_source=openai, https://www.gurufocus.com/news/8588626/once-upon-a-farm-announces-pricing-of-initial-public-offering?utm_source=openai, https://www.investing.com/news/stock-market-news/brazils-agibank-aims-to-raise-7855-million-in-us-ipo-4474336?utm_source=openai, https://www.prnewswire.com/news-releases/liftoff-announces-launch-of-initial-public-offering-302674271.html?utm_source=openai, https://www.renaissancecapital.com/IPO-Center/News/116591/Brazilian-consumer-bank-AGI-sets-terms-for-%24720-million-US-IPO?utm_source=openai, https://www.renaissancecapital.com/IPO-Center/News/116625/Solar-project-builder-SOLV-Energy-sets-terms-for-%24482-million-IPO?utm_source=openai, https://www.rttnews.com/3618389/belgian-biotech-agomab-therapeutics-to-debut-on-nasdaq-at-16-per-ads.aspx?utm_source=openai, https://www.solvenergy.com/news/solv-energy-announces-launch-of-initial-public-offering?utm_source=openai
Disclaimer
This research report is for informational purposes only and does not constitute investment advice. All information is sourced from publicly available data and should be verified independently. Past performance does not guarantee future results.
Generated on: 2026-02-06 at 11:23 UTC
Source: Alpha Signal Monitor - Automated Research System
Contact: For questions about this report, please contact your Alpha Signal Monitor administrator.
Powered by Alpha Signal Monitor | Market Intelligence Through AI